The nation of Zimbabwe has rejected a substantial US health deal worth $367m (272 million pounds) over five years over the United States' demand for confidential data.
This move became public after a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government representative has since clarified that the US was seeking health data for research and commercial gain while was not willing to guarantee the benefits from any future vaccines.
"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for continued negotiations to find a agreement acceptable to all parties so the nation's vital HIV treatment initiative can proceed.
Broader Context
This development comes after a comparable case in neighbouring Kenya, where a court blocked a related health funding agreement after legal challenges were filed about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had managed aid for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and accountability.
As per reports, 16 nations in Africa have to date agreed to these new health pacts, representing over $18.3bn in new funding.
Details of the Rejected Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy through American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to share its genetic material and health information indefinitely, with no corresponding assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Effectively, our nation would supply the raw materials for medical research without any certainty that the resulting innovations would be available to our population if a new disease outbreak emerge."
National Interest and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems already set up through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to manage potential global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage further discussions with our US partners on how future co-operation might be arranged in a way that honours the sovereignty and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but suggested that talks must proceed since a large portion of the nation's Aids initiatives depended on international support.
"Where technical issues exist, such as those involving data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group said.
The halted deal highlights the continuing challenges between accepting crucial foreign assistance and protecting a country's data in an ever more interconnected world.